JW Pharmaceutical: Diabetes Mellitus, Type 2 trials

The registry lists 10 Diabetes Mellitus, Type 2 studies with JW Pharmaceutical as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 2 1Phase 3 4Phase 4 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Glycemic Variability of Combination Therapies in T2DMRecruitingNCT07442006Phase 4
• Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With HypercholesterolemiaCompletedNCT00889226Phase 4Results posted
• To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DMCompletedNCT05814406Phase 3
• To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes MellitusCompletedNCT05814393Phase 3
• MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes MellitusCompletedNCT04810507Phase 4
• Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DMStatus unknownNCT04267601
• Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin AloneCompletedNCT01529541Phase 3
• A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus PatientsCompletedNCT01529528Phase 3
• Therapeutic Exploratory Study of CWP-0403CompletedNCT00888719Phase 2
• Glufast On Insulin Glargine Trial in Type 2 DMCompletedNCT00663884Phase 4